New conditions imposed on Grifols by Health Canada, CBC News reports

Health Canada has imposed new terms and conditions on all of Grifols (GRFS)’ paid plasma centers following multiple failed inspections that identified recurring systemic deficiencies, including inadequate donor screening, poor investigation of errors, insufficient staff training, and failure to follow operating procedures, Kristin Annable and Michelle Allan of CBC News reports. The action follows two donor deaths in Winnipeg and deficiencies found during an inspection of the company’s Canadian head office, which oversees all 16 collection sites. A spokesperson for Health Canada says the conditions will remain in place until Grifols shows “sustained compliance” with blood regulations at all licensed sites.